Contract notice: Pharmaceutical products Tender, Germany - 14996490

Procurement Summary

Country : Germany

Summary : Contract notice: Pharmaceutical products

Deadline : 05 Jul 2019

Other Information

Notice Type : Tender

TOT Ref.No.: 14996490

Document Ref. No. : 278569-2017

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : DAK-GESUNDHEIT
Office Name: DAK-Gesundheit
Address: Nagelsweg 27-31
Town: Hamburg
Postal Code: 20097


Phone: +49 402396-2682
Fax: +49 402396-3661
Germany
Email :vergabestelle@dak.de
URL :www.dak.de

Tender Details

Object of the contract
Pharmaceutical products

Description: Contract notice: Pharmaceutical products

Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union
Award criteria: Lowest price
CPV code: 33600000, 33600000
CPV Description: Pharmaceutical products.

Completion of a non-exclusive discount agreement pursuant to - 130a Abs. 8 SGB V to the active substance Midazolam, ATC N05CD08, for the period Allows the health insurance companies and pharmaceutical companies to contract the framework agreements on the medicinal products to be distributed to the statutory health insurance funds-conclude. With regard to the statutory provisions governing the award of public contracts, a regular process of drug-related, so-called tendering procedure takes place according to the regulations of the fourth part of the GWB by the DAK-G. For medicinal products to be designated by the tenderer closer to the active substance midazolam, ATC N05CD08 in Annex 2 to the contract, the-DAK-G, to conclude drug discounts with the latest pharmaceutical sales contracts with pharmaceutical companies with the highest possible number of pharmaceutical companies. A discount agreement within the scope of the admission model for the above- Active substance enters into force for the first time on 1.9.2017 and ends on 31.8.2019. It ends automatically with the entry into force of the exclusive contract.

The DAK-G goes-Assuming that this procedure does not come within the scope of the antitrust law because of the lack of a selection decision and the non-discriminatory accessibility of all pharmaceutical companies. It shall terminate automatically, with the entry into force of the exclusive agreement to Midazolam, ATC N05CD08, as a result of a procurement procedure under RegThird part of the GWB with one or more contract partners. In order to meet the diversity of the potential contract partners within the framework of the licensing model, each pharmaceutical company is allowed to conclude a framework contract at any time and under the same conditions during the contract period. The contract documents required for this purpose are available through OnliNe portal www.dtvp.de/center under the heading I.3., The complete and timely transmission of the following proofs / explanations / attachments (available for download under the conditions described under I. 3) referred to in the followingContact person at the DAK-G:

1. Letter of Offer.

2. Current proof of entry in the professional or commercial register (see III.1.1.)

3. Declaration by the company (Annex A1) that none of the exclusion criteria is in accordance with -- 123, 124 GWB (see III.1.1.). Declare that for those medicinal products for which the interested party has a contract under this document, (A), and that the tenderer is entitled to sell at the start of the contract (Annex A2) (see III.1.1.)

5. Declaration by the company that the statutory provisions on the minimum wage and tariff refusal are respected and complied with (Annex A3) (see III.1.1.). Recognition of the contractual provisions of the DAK health, On the other hand, also the given discount by signing the contract stamped with a company stamp (2 times in the original) by the interested party in the designated place. The completed enclosures 1 and 2 to the contract (2-fold in the original). The interested party here has the drugs to the above. Substance, which shall be the object of the contract. Effective prequalification(DAK-Gesundheit, Henri Affinass (0032 50), Nagelsweg 27-31, 20097 Hamburg, Germany Further information on the DAK health (see III.1.1 and III.1.2.) The documents are to be submitted by post The attachment 2 as an excel file is sent simultaneously to the mail address am_rabattvertraege@dak.de. Contracts within the scope of this model and to the above. The active substance will be used for the first time with effect from 1.9.2017 and end on 31.8.2019. Interested parties wishing to become contractors on this date have the documents to be submitted by the 5th of the previous month, Position. This is due to the timely access to DAK health. Later accessions are possible at any time. For the duration of the contract to the 1st or 15th of the following month, Eten, the above- Documents, irrespective of the desired accession, of the DAK health up to the 5th of the previous month. This also applies to the timely access to the DAK-G. Example: The bidding requested by the bidder is to take place on 15.7.20xx (follow-up), the documents have to be submitted by 5.6.20xx (previous month)Is done here using the form for open procedures. As already made clear, this is not such a notice had to be used for technical reasons, since there is no suitable form for approval procedure. Current proof of entry in the professional or trade register (not more than 6 months in case of dispatch) according to the provisions-Of the legislation of the country in which the undertaking is a resident, Eg current commercial register extract; Copy is sufficient.

2. Declaration by the company that none of the exclusion criteria is in accordance with -- 123, 124 GWB. To this end, the A1 is to be signed, to be stamped with the company stamp and to be submitted in the original. It is self-declaration, that for those drugsFor which the interested party wishes to conclude a contract in the context of the present procedure, has an authorization under the law on medicinal products, and that the tenderer is entitled to distribute it at the start of the contract (Annex A2) (see III.1.1.). Declaration of the company that the statutory provisions on the minimum wage and the tariff refusal are observed and complied with (Annex A3). For this purpose the A(DAK-Gesundheit) has published a so-called pre-qualification procedure for pharmaceutical companies for the simplified participation in future drug discounts (EU-announcement 2015 / S 105-190319 of 3.6 .2015). Insofar as the tenderer(Proof of the entry in the professional or trade register, the company's own declaration that none of the exclusion criteria according to -- 123, 124 GWB is available, Certification of the statutory health insurance)The copy of the pre-qualification certificate. Annex A2 is to be added in all cases. The pre-qualification certificate of the DAK health is also used as evidence for open-house DAK health procedures, regardless of the value of the order-Would be subject to authorization under the drug law and that the tenderer is entitled to sell at the start of the contract. For this purpose, the attachment A2 has to be signed, stamped with the company stamp and submitted in the original. The DAK health has a so-called prequalification procedure for pharmaceutical companies through the European publicity platform(See EU notice 2015 / S 105-190319 of 3 June 2015). This information is intended to be If the bidder has received an effective pre-qualification notice from the DAK health in good time before submission of the dossier, he needs the company-specific aptitude test (proof of the entry in the professional or hand)Elsregister, declaration of the company that none of the exclusion criteria according to. -- 123, 124 GWB, safety certificate of the statutory health insurance fund) with copy and annex of the prequalification certificate in copy no more. Annex A2 is to be added in all cases. The prequalification requirement for DAK health also serves as a proofIs open-house procedures for DAK health.

The contract documents can also be sent by e-mail to the address given under I.1. Must be requested. The tender documents will then be sent by e-mail. Questions and notes on the tender documents are available electronically (by means of the bidding communication via the award portal www.dtvp.de) or in need(By fax or letter) to the persons mentioned under I.1. Contact point. They are to be formulated in German. Responses will be made available in anonymous form to all contractors who requested the registration documents by means of a registration. In doing so, the replies are sent to the entrepreneurs by way of biddersTion on the award portal www.dtvp.de. Companies who have downloaded the tender documents without registration must, on their own responsibility, pursue the further communication and, if necessary, This publication is not a public procurement contract within the meaning of VDirective 2014/24 / EU of the European Parliament and of the Council and of the In order to ensure the widest degree of transparency for the intended

contract conclusion, the supplement is published in the Official Journal of the European Union. In the absence of a corresponding publication form, the contract notice shall be usedt. The resulting conceptual specifications, such as, for example, the procedure description "Open procedure", are solely due to the use of this publication form and to the publishing platform connected.

Most well-tmachungs-ID: CXP4YM5YE73.


Internet address (URL): www.dak.de
Directive: Classical Directive (2014/24/EU)

Documents

 Tender Notice